Clinical Endocannabinoid Deficiency was a theory posited by Dr. Russo back in 2001 in which he theorized that low endocannabinoid levels could be behind a range of chronic conditions such as IBS, fibromyalgia, migraines, and other treatment-resistant syndromes. Dr. Russo suggested that because these conditions are all developed over time, rather than congenitally, and that they could be a result of disturbances to the ECS. This also means there’s a possibility of reversing them.
The incident involving Cost Cannabis in Revelstoke, British Columbia, raises significant questions about pricing strategies…
He emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from…
"How Long Does One Puff of Weed Stay in Your System?"... This topic can be difficult…
GMO x Purple Punch deliver a knockout. The post Sleep through it all with Modified…
As the popularity of CBD (cannabidiol) continues to rise, many pet owners are exploring its…
An intriguing trend has emerged In recent years within the world of professional golf: a…